VIR

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Vir Biotechnology Inc

NASDAQ | VIR

6.43

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 28, 2025)

$889.01M

Market Cap

-

P/E Ratio

-3.62

EPS

$14.45

52 Week High

$4.15

52 Week Low

HEALTHCARE

Sector

VIR Chart

Recent Chart
Price Action

VIR Technicals

Tags:

VIR Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$404M
Total Revenue $74M
Cost Of Revenue $479M
Costof Goods And Services Sold $479M
Operating Income -$587M
Selling General And Administrative $119M
Research And Development $506M
Operating Expenses $183M
Investment Income Net -
Net Interest Income $72M
Interest Income $72M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $15M
Income Before Tax -$523M
Income Tax Expense -$1.1M
Interest And Debt Expense -
Net Income From Continuing Operations -$522M
Comprehensive Income Net Of Tax -
Ebit -$523M
Ebitda -$509M
Net Income -$522M

Revenue & Profitability

Earnings Performance

VIR Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $1.4B
Total Current Assets $1B
Cash And Cash Equivalents At Carrying Value $223M
Cash And Short Term Investments $223M
Inventory -
Current Net Receivables $5.1M
Total Non Current Assets $356M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $8.1M
Intangible Assets Excluding Goodwill $8.1M
Goodwill $17M
Investments -
Long Term Investments $190M
Short Term Investments $682M
Other Current Assets $137M
Other Non Current Assets -
Total Liabilities $248M
Total Current Liabilities $120M
Current Accounts Payable $5.1M
Deferred Revenue -
Current Debt -
Short Term Debt $7.8M
Total Non Current Liabilities $129M
Capital Lease Obligations $98M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $98M
Other Current Liabilities $94M
Other Non Current Liabilities $39M
Total Shareholder Equity $1.2B
Treasury Stock -
Retained Earnings -$760M
Common Stock $14K
Common Stock Shares Outstanding $136M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$446M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $15M
Capital Expenditures $7.3M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $499M
Cashflow From Financing $4.4M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$522M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$404M
Total Revenue $74M
Cost Of Revenue $479M
Costof Goods And Services Sold $479M
Operating Income -$587M
Selling General And Administrative $119M
Research And Development $506M
Operating Expenses $183M
Investment Income Net -
Net Interest Income $72M
Interest Income $72M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $15M
Income Before Tax -$523M
Income Tax Expense -$1.1M
Interest And Debt Expense -
Net Income From Continuing Operations -$522M
Comprehensive Income Net Of Tax -
Ebit -$523M
Ebitda -$509M
Net Income -$522M

VIR News

VIR Profile

Vir Biotechnology Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Vir Biotechnology, Inc. is a clinical-stage immunology company based in San Francisco, California, specializing in the development of innovative therapeutic solutions for serious infectious diseases. The company leverages its proprietary technologies and a robust pipeline that includes advanced monoclonal antibodies and immunotherapeutics to address significant unmet medical needs, particularly in viral infections like COVID-19 and influenza. Through strategic partnerships and collaborations, Vir enhances its research capabilities and positions itself as a pivotal entity in the biotechnology sector, committed to advancing global health outcomes.

LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
BYND
+19.00%
$1.02
KTTA
+54.72%
$1.64
VINE
+10.76%
$0.39
AMZE
+28.66%
$0.50
IPG
-1.95%
$24.57
TLRY
-20.11%
$0.82
NVDA
-1.76%
$177.08
AXDX
-61.36%
$0.03
YGMZ
-10.65%
$0.10
BITF
+11.80%
$3.46
ADAP
-15.14%
$0.05
INTC
+7.72%
$39.65
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
RUBI
-18.08%
$0.17
RIG
+6.17%
$4.30
SRM
+53.27%
$10.30
BIYA
+11.30%
$0.28
AGNC
+1.53%
$10.56
CLSK
+14.57%
$15.41
TWOH
0.00%
$0.00
INHD
-1.55%
$0.22
WLGS
-5.57%
$0.04
BMNR
+6.26%
$33.72
MTSR
-0.35%
$70.50
ONMD
+45.07%
$2.06
SNAP
-0.01%
$7.60
ASST
+0.88%
$1.14
TSLA
+0.55%
$428.96
PCG
+1.78%
$16.01
PLUG
+2.09%
$2.02
AFMD
-34.94%
$0.18
ADTX
+18.78%
$3.72
MARA
+5.02%
$11.66
GPUS
-6.69%
$0.31
NVTS
+3.86%
$8.34
KWM
+12.77%
$0.74
CHR
-4.18%
$0.04
BMNU
+14.89%
$8.64
F
+0.68%
$13.28
GRYP
-10.38%
$1.38
CIFR
+8.28%
$20.73
MODV
-25.22%
$0.43
AMCR
+1.29%
$8.62
ONDS
-2.81%
$8.00
TEVA
+5.32%
$26.32
CRCL
+11.05%
$80.67
KDLY
+7.20%
$0.49
AAL
+0.60%
$14.01
CSCO
-0.32%
$76.07
DEFT
+10.43%
$1.53
IBRX
+11.50%
$2.37
CAN
+12.59%
$1.03
WULF
+5.18%
$15.61
GOOGL
-0.34%
$318.85
IREN
-0.44%
$48.23
BTBT
+2.58%
$2.38
BURU
+5.44%
$0.23
SAND
-6.04%
$12.12
RIOT
+9.45%
$16.37
NIO
+0.64%
$5.49
SMX
+166.32%
$46.34
DVLT
-3.75%
$2.05
SHOT
-74.37%
$0.39
ZAPP
-46.30%
$0.15
APLD
+7.21%
$26.74
GRAB
+2.67%
$5.46
AG
+12.27%
$15.16
GOOG
-0.73%
$317.92
BTG
+2.92%
$4.60
AMD
+0.97%
$216.32
SOFI
+2.47%
$29.19
KO
+0.37%
$72.88
VALE
+0.63%
$12.59
C
+1.31%
$102.50
CRCA
+22.96%
$4.52
ABVE
+16.17%
$3.05
NEHC
+8.33%
$5.07
COMP
-0.76%
$10.42
CDE
+6.02%
$17.16
ACHR
+4.07%
$7.79
RF
+0.11%
$25.45
KEY
+0.16%
$18.40
MSTR
+2.73%
$180.44
DNN
+1.09%
$2.58
WIT
-0.37%
$2.69
ZIM
+0.97%
$19.70
CRCG
+20.69%
$2.83
AMC
+6.95%
$2.46
PLTR
+0.77%
$167.05
MPW
+2.12%
$5.77
AMZN
+1.25%
$232.04
IVP
-7.66%
$0.12
TMC
+10.72%
$6.45
SNDK
+3.75%
$223.12
SMR
+4.80%
$19.95
LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
BYND
+19.00%
$1.02
KTTA
+54.72%
$1.64
VINE
+10.76%
$0.39
AMZE
+28.66%
$0.50
IPG
-1.95%
$24.57
TLRY
-20.11%
$0.82
NVDA
-1.76%
$177.08
AXDX
-61.36%
$0.03
YGMZ
-10.65%
$0.10
BITF
+11.80%
$3.46
ADAP
-15.14%
$0.05
INTC
+7.72%
$39.65
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
RUBI
-18.08%
$0.17
RIG
+6.17%
$4.30
SRM
+53.27%
$10.30
BIYA
+11.30%
$0.28
AGNC
+1.53%
$10.56
CLSK
+14.57%
$15.41
TWOH
0.00%
$0.00
INHD
-1.55%
$0.22
WLGS
-5.57%
$0.04
BMNR
+6.26%
$33.72
MTSR
-0.35%
$70.50
ONMD
+45.07%
$2.06
SNAP
-0.01%
$7.60
ASST
+0.88%
$1.14
TSLA
+0.55%
$428.96
PCG
+1.78%
$16.01
PLUG
+2.09%
$2.02
AFMD
-34.94%
$0.18
ADTX
+18.78%
$3.72
MARA
+5.02%
$11.66
GPUS
-6.69%
$0.31
NVTS
+3.86%
$8.34
KWM
+12.77%
$0.74
CHR
-4.18%
$0.04
BMNU
+14.89%
$8.64
F
+0.68%
$13.28
GRYP
-10.38%
$1.38
CIFR
+8.28%
$20.73
MODV
-25.22%
$0.43
AMCR
+1.29%
$8.62
ONDS
-2.81%
$8.00
TEVA
+5.32%
$26.32
CRCL
+11.05%
$80.67
KDLY
+7.20%
$0.49
AAL
+0.60%
$14.01
CSCO
-0.32%
$76.07
DEFT
+10.43%
$1.53
IBRX
+11.50%
$2.37
CAN
+12.59%
$1.03
WULF
+5.18%
$15.61
GOOGL
-0.34%
$318.85
IREN
-0.44%
$48.23
BTBT
+2.58%
$2.38
BURU
+5.44%
$0.23
SAND
-6.04%
$12.12
RIOT
+9.45%
$16.37
NIO
+0.64%
$5.49
SMX
+166.32%
$46.34
DVLT
-3.75%
$2.05
SHOT
-74.37%
$0.39
ZAPP
-46.30%
$0.15
APLD
+7.21%
$26.74
GRAB
+2.67%
$5.46
AG
+12.27%
$15.16
GOOG
-0.73%
$317.92
BTG
+2.92%
$4.60
AMD
+0.97%
$216.32
SOFI
+2.47%
$29.19
KO
+0.37%
$72.88
VALE
+0.63%
$12.59
C
+1.31%
$102.50
CRCA
+22.96%
$4.52
ABVE
+16.17%
$3.05
NEHC
+8.33%
$5.07
COMP
-0.76%
$10.42
CDE
+6.02%
$17.16
ACHR
+4.07%
$7.79
RF
+0.11%
$25.45
KEY
+0.16%
$18.40
MSTR
+2.73%
$180.44
DNN
+1.09%
$2.58
WIT
-0.37%
$2.69
ZIM
+0.97%
$19.70
CRCG
+20.69%
$2.83
AMC
+6.95%
$2.46
PLTR
+0.77%
$167.05
MPW
+2.12%
$5.77
AMZN
+1.25%
$232.04
IVP
-7.66%
$0.12
TMC
+10.72%
$6.45
SNDK
+3.75%
$223.12
SMR
+4.80%
$19.95
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.